2,5-Dioxopyrrolidin-1-yl but-3-enoate

Catalog No. :
ACGDSA763
CAS No. :
388091-45-0
Molecular Formula :
C8H9NO4
Molecular Weight :
183.16

IUPAC Name:2,5-dioxopyrrolidin-1-yl but-3-enoate

2,5-Dioxopyrrolidin-1-yl but-3-enoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$92.00Login to see priceInquiryInquiry
100mg97%$127.00Login to see priceInquiryInquiry
250mg97%$174.00Login to see priceInquiryInquiry
1g97%$334.00Login to see priceInquiryInquiry
5g97%$825.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5-Dioxopyrrolidin-1-yl but-3-enoate
IUPAC Name2,5-dioxopyrrolidin-1-yl but-3-enoate
MDL No.MFCD08457688
Molecular FormulaC8H9NO4
Molecular Weight183.16
SMILESO=C(CC1)N(OC(CC=C)=O)C1=O
InChI KeyATYWAFUUESAUHS-UHFFFAOYSA-N
Synonym2,5-Pyrrolidinedione,1-[(1-oxo-3-butenyl)oxy]-(9CI);2,5-Dioxopyrrolidin-1-yl but-3-enoate;3-Butenoic acid, 2,5-dioxo-1-pyrrolidinyl ester
CAS No.388091-45-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGDSA763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6 In Stock
  4. Then
  5. ACGDSA763 route product structure diagram
    ACGDSA763388091-45-0
Inquiry

2. ACGDSA763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6 In Stock
  4. Then
  5. ACGDSA763 route product structure diagram
    ACGDSA763388091-45-0
Inquiry

Comments (0)